Solid Biosciences

Solid Biosciences

  • Founded: 2013
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin0
  • Therapy area: DMD
  • Drug types: GEN, MUS, NEU, CVV, RAR
  • Lead product: SGT-003
  • Product link: https://www.solidbio.com/research-development/pipeline-programs/pipeline
  • Funding: $144M stock Mar 2021; $90M stock (PP) Dec 2020; $60M stock (PP) Jul 2019; $134M IPO Jan 2018


solidbio.com

linkedin.com

job board


Short description:

Gene Therapy, Devices, Biologics, Small Molecules all for DMD

Drug notes:

ABV-202 Clin0 Friedreich's ataxia; AVB-401 Clin0 dilated cardiomyopathy; undisclosed Clin0 cardiac condition

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Solid Biosciences
Manager, People and Patient Engagement
Boston|1 day ago
Apply
Solid Biosciences
Director/Sr Director Technical Quality
Boston, Massachusetts, Stati Uniti d'America|1 day ago
Solid Biosciences
IT and Business Applications Manager
Greater Boston|7 days ago
Solid Biosciences
Director of Investor Relations/Corporate Communica...
Greater Boston|19 days ago
Solid Biosciences
Sr Scientist, Analytical Development
Greater Boston|26 days ago
Solid Biosciences
Director, Clinical Science
Greater Boston|30 days ago
Solid Biosciences
Scientist- Cardiac Disease
Greater Boston|42 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com